Biochemical and pharmacological study of venom of the wolf spider Lycosa singoriensis

Journal of Venomous Animals and Toxins Including Tropical Diseases

Volumn 15, Issue 1, 2009, Pages 79-92

  Liu, Z H ^a   Qian, W ^b   Li, J ^a   Zhang, Y ^a   Liang, Songping ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

^b Administrative Center for Basic Research   (China)

Author keywords

Antimicrobial activity; Crude venom; Lycosa singoriensis; MALDI TOF; Spider

Indexed keywords

SPIDER VENOM;

ANTIMICROBIAL ACTIVITY; ARTICLE; BIOCHEMISTRY; CHINA; DRUG EFFECT; ERYTHROCYTE; EUKARYOTIC CELL; HEMOLYSIS; HUMAN; HUMAN CELL; LYCOSA SINGORIENSIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NEUROTOXICITY; NONHUMAN; PROKARYOTIC CELL; PROTEIN CONTENT; SPIDER;

ARANEAE; EUKARYOTA; LYCOSA SINGORIENSIS; LYCOSIDAE; MUS; PROKARYOTA;

EID: 65749088859     PISSN: 16789199     EISSN: 16789199     Source Type: Journal    
DOI: 10.1590/S1678-91992009000100008     Document Type: Article

References (31)

1. Corzo G, Escoubas P. Pharmacologically active spider peptide toxins. Cell Mol Life Sci. 2003;60(11):2409-2426
2. Escoubas P. Molecular diversification in spider venoms: a web of combinatorial peptide libraries. Mol Divers. 2006;10(4):545-554
3. King GF. The wonderful world of spiders: preface to the special Toxicon issue on spider venoms. Toxicon. 2004;43(5):471-475 (Pubitemid 38520190)
4. Escoubas P, Rash L. Tarantulas: eight-legged pharmacists and combinatorial chemists. Toxicon. 2004;43(5):555-574 (Pubitemid 38520196)
5. Escoubas P, Sollod B, King GF. Venom landscapes: mining the complexity of spider venoms via a combined cDNA and mass spectrometric approach. Toxicon. 2006;47(6):650-663
6. Sollod BL, Wilson D, Zhaxybayeva O, Gogarten JP, Drinkwater R, King GF. Were arachnids the first to use combinatorial peptide libraries? Peptides. 2005;26(1):131-139 (Pubitemid 40038886)
7. Tedford HW, Sollod BL, Maggio F, King GF. Australian funnel-web spiders: master insecticide chemists. Toxicon. 2004;43(5):601-618
8. Lu DL, Zhang DF. Two kinds of poisonous spiders in Xinjiang and prevention and cure for the spider bite. Chin J Zool. 2001;36(5):40-42
9. Initial observation on living habit of Lycosa singorensis. Chin J Zool. 2004;39:63-67
10. Liu Z, Dai J, Dai L, Deng M, Hu Z, Hu W, Liang S. Function and solution structure of huwentoxin-X, a specific blocker of N-type calcium channels, from the Chinese bird spider Ornithoctonus huwena. J Biol Chem. 2006;281(13):8628- 8635 (Pubitemid 43847967)
11. Bulbring E. Observations on the isolated phrenic nerve diaphragm preparation of the rat. Br J Pharmacol Chemother. 1946;1(1):38-61.
12. Liang SP, Chen XD, Shu Q, Zhang Y, Peng K. The presynaptic activity of huwentoxin-I, a neurotoxin from the venom of the Chinese bird spider Selenocosmia huwena. Toxicon. 2000;38(9):1237-1246 (Pubitemid 30151140)
13. Guette C, Legros C, Tournois G, Goyffon M, Célérier ML. Peptide profiling by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry of the Lasiodora parahybana tarantula venom gland. Toxicon. 2006;47(6):640-649
14. Liang S. An overview of peptide toxins from the venom of the Chinese bird spider Selenocosmia huwena Wang [=Ornithoctonus huwena (Wang)]. Toxicon. 2004;43(5):575-585
15. Liao Z, Cao J, Li S, Yan X, Hu W, He Q, Chen J, Tang J, Xie J, Liang S. Proteomic and peptidomic analysis of the venom from Chinese tarantula Chilobrachys jingzhao. Proteomics. 2007;7(11):1892-1907
16. Yuan C, Jin Q, Tang X, Hu W, Cao R, Yang S, Xiong J, Xie C, Xie J, Liang S. Proteomic and peptidomic characterization of the venom from the Chinese bird spider, Ornithoctonus huwena Wang. J Proteome Res. 2007;6(7):2792-2801
17. Endoh M. A Na+ channel agonist: a potential cardiotonic agent with a novel mechanism? Br J Pharmacol. 2004;143(6):663-665 (Pubitemid 39611602)
18. Budnik BA, Olsen JV, Egorov TA, Anisimova VE, Galkina TG, Musolyamov AK, Grishin EV, Zubarev RA. De novo sequencing of antimicrobial peptides isolated from the venom glands of the wolf spider Lycosa singoriensis. J Mass Spectrom. 2004;39(2):193-201. (Pubitemid 38292495)
19. Yan L, Adams ME. Lycotoxins, antimicrobial peptides from venom of the wolf spider Lycosa carolinensis. J Biol Chem. 1998;273(4):2059-2066
20. Kuhn-Nentwig L, Dathe M, Walz A, Schaller J, Nentwig W. Cupiennin 1d: the cytolytic activity depends on the hydrophobic N-terminus and is modulated by the polar C-terminus. FEBS Lett. 2002;527(1-3):193-198 (Pubitemid 35253864)
21. Kuhn-Nentwig L, Muller J, Schaller J, Walz A, Dathe M, Nentwig W. Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae). J Biol Chem. 2002;277(13):11208-11216
22. Pukala TL, Doyle JR, Llewellyn LE, Kuhn-Nentwig L, Apponyi MA, Separovic F, Bowie JH. Cupiennin 1a, an antimicrobial peptide from the venom of the neotropical wandering spider Cupiennius salei, also inhibits the formation of nitric oxide by neuronal nitric oxide synthase. FEBS J. 2007;274(7):1778-1784
23. Corzo G, Villegas E, Gomez-Lagunas F, Possani LD, Belokoneva OS, Nakajima T. Oxyopinins, large amphipathic peptides isolated from the venom of the wolf spider Oxyopes kitabensis with cytolytic properties and positive insecticidal cooperativity with spider neurotoxins. J Biol Chem. 2002;277(26):23627-23637
24. Nomura K, Corzo G. The effect of binding of spider-derived antimicrobial peptides, oxyopinins, on lipid membranes. Biochim Biophys Acta. 2006;1758(9):1475-1482
25. Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV. Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity. J Biol Chem. 2006;281(30):20983-20992
26. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol. 2005;3(3):238-250
27. Brown KL, Hancock RE. Cationic host defense (antimicrobial) peptides. Curr Opin Immunol. 2006;18(1):24-30.
28. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415(6870):389-395
29. Matsuzaki K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta. 1999;1462(1-2):1-10.
30. Mcphee JB, Hancock RE. Function and therapeutic potential of host defence peptides. J Pept Sci. 2005;11(11):677-687
31. Mookherjee N, Hancock RE. Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell Mol Life Sci. 2007;64(7-8):922-933 (Pubitemid 46597762)